Development of novel platforms for cancer immunotherapy
The IVTLab is an international and interdisciplinary laboratory promoting cutting-edge research in the field of oncoimmunology and immunotherapy using viruses as platforms to induce and/or orchestrate the tumor-specific immune response. The laboratory is well supported and funded by prestigious and internationally recognised funding agencies such as the European Research Council Consolidator grant (ERC-CoG), HiLIFE, Jane and Aatos Erkko Foundation and Tekes.
Twitter and News
Battle with the cancer: new avenues from childhood vaccines
A new research from University of Helsinki showed for the first time how the pre-immunization acquired through common childhood vaccines can be...
What could decision-makers do to promote science-based innovation?
Member of Parliament Juhana Vartiainen and Professor, Founder and VALO therapeutic Founder Vincenzo Cerullo discuss during Slush 2019 how to...
Members of the ImmunoViroTherapy Lab
The group consists of many experts and researchers with outstanding knowledge in the field of immunovirotherapy.
One of my main priorities is promoting science to non-scientific audience and I believe that it has never been a better time then now to do...